Have any thoughts about
Medibio Ltd?
Write Note

Net Margin
Medibio Ltd

-323.7%
Current
-526%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-323.7%
=
Net Income
-3.1m
/
Revenue
963.8k

Net Margin Across Competitors

Country AU
Market Cap 122m AUD
Net Margin
-324%
Country US
Market Cap 35.3B USD
Net Margin
25%
Country US
Market Cap 31.3B USD
Net Margin
10%
Country AU
Market Cap 26.1B AUD
Net Margin
50%
Country US
Market Cap 10.9B USD
Net Margin
34%
Country US
Market Cap 6.5B USD
Net Margin
-6%
Country JP
Market Cap 934B JPY
Net Margin
16%
Country US
Market Cap 5.6B USD
Net Margin
4%
Country SE
Market Cap 53.2B SEK
Net Margin
25%
Country US
Market Cap 2.4B EUR
Net Margin
-4%
Country CN
Market Cap 16B CNY
Net Margin
11%
No Stocks Found

Medibio Ltd
Glance View

Market Cap
122m AUD
Industry
Health Care

Medibio Ltd. engages in the clinical research, product development and early stage commercialization of a mental health technology. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2001-01-29. The firm offers mental well-being solutions for businesses and are also developing products to serve the healthcare provider market. The company offers a software called MEBsleep, a medical device that analyses Electroencephalogram (EEG) and Electrocardiogram (ECG) data collected during polysomnography to verify sleep stages and heart rate variability (HRV) in patients suffering from primary or secondary sleep disturbances. The Company’s subsidiaries include Bioprospect Australia Pty Ltd, Australian Phytochemicals Pty Ltd, BioProspect America Pty Ltd, Medibio Limited USA, Invatec Health Pty Ltd and Annapanna Pty Ltd.

MEB Intrinsic Value
0.001 AUD
Overvaluation 97%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-323.7%
=
Net Income
-3.1m
/
Revenue
963.8k
What is the Net Margin of Medibio Ltd?

Based on Medibio Ltd's most recent financial statements, the company has Net Margin of -323.7%.